Simplify Logo

Full-Time

Principal Engineer

Automation

Posted on 3/1/2024

Verve Therapeutics

Verve Therapeutics

201-500 employees

Developing gene editing therapies for heart disease

Hardware
Biotechnology
Healthcare

Senior, Expert

Cambridge, MA, USA

Category
Backend Engineering
IT & Support
Security Engineering Management
Software Engineering
Required Skills
Python
SQL
Java
MATLAB
Data Analysis
Requirements
  • PhD in life sciences or engineering field with 6+ years of relevant industry experience
  • or M.S in life sciences or engineering field with 8+ years of relevant industry experience
  • or B.S. in life sciences or engineering field with 12+ years relevant industry experience
  • Experience implementing automation in genomics and NGS workflows is highly preferred
  • Strong technical background and familiarity with a wide range of automation technologies, including hardware and software systems, control systems, robotics, and data analytics
  • Previous experience with liquid handling platforms, laboratory automation equipment including Hamilton, Tecan, and Agilent based systems is required
  • Demonstrate advanced programming expertise with commercial liquid handlers and HTS software is required (Venus on Vantage, Fluent Control, and VWorks)
  • Experience implementing fully automated, end-to-end automation solutions, such as High Res Bio Systems or Biosero is desirable
  • Experience with and operational knowledge of immunoassay/ELISA based instruments such as flow cytometers, MesoScale, BioTek, Cytomat, and Multi-mode plate readers
  • Programming knowledge in .NET (VB, C#, ASP), Python, Java Script, SQL server, VBA Excel and Matlab are highly desired
  • Strong familiarity with the gene therapy development and discovery process
  • Experience leading a team of engineers and mentoring them as they progress in their careers
  • Excellent analytical and problem-solving skills, with the ability to identify and solve complex problems
  • Effective communicator with the ability to explain technical concepts to non-technical stakeholders and collaborate with cross-functional teams effectively
Responsibilities
  • Lead an in-house automation team to implement automation across the company to increase efficiency, standardization, and throughput of NGS workflows
  • Develop near-, mid-, and long-term strategies to automate various processes across different R&D groups, including NGS, Analytical Development, RNA Technology teams and more
  • Work closely with cross-functional teams, including, scientists, engineers, and IT professionals to identify opportunities for automation and ensure successful implementation of automation systems
  • Oversee the implementation of automation systems, including selecting appropriate hardware and software, configuring systems, testing and troubleshooting, and providing training to end-users
  • Manage automation projects from conception to completion, ensuring that projects are completed on time, within budget, and meet the desired objectives
  • Stay up to date with the latest developments in automation technology and industry best practices to ensure that Verve are at the forefront of automation innovation
  • Ensure that data generated using automation is accurate, reliable, and auditable and of the highest quality
  • Work with others in the automation team to script new methods, integrate hardware and optimize existing methods to enable high-throughput solutions used by internal teams.
  • Manage a fleet of liquid handling platforms, including creating SOPs, maintaining fleet health and scheduling preventative maintenance.
  • Work closely with Computational Biology, Quality Assurance, Quality Control, Information Technology, and Regulatory groups to ensure conformance of automation workflows with regulatory requirements as appropriate
  • Demonstrate exceptional time management skills and drive to support automation adoption and increase data output
  • Other duties as assigned

Verve Therapeutics is developing single-course gene editing medicines to address cardiovascular disease, with a focus on precision genetic editing technologies to lower LDL cholesterol and triglyceride levels. Their lead program, VERVE-101, targets heterozygous familial hypercholesterolemia, a potentially fatal genetic heart disease.

Company Stage

IPO

Total Funding

$419.3M

Headquarters

Cambridge, Massachusetts

Founded

2018

Growth & Insights
Headcount

6 month growth

7%

1 year growth

5%

2 year growth

54%
INACTIVE